- Rita Medical Systems Inc.
- Curon Medical Inc.
- Acuson Corp.
- Nuvelo Inc.
- Ingenium Pharmaceuticals AG
- bioMerieux SA
- Pierre Fabre Group
- Amelung GmbH
- Merck Serono SA
- Genzyme Corp.
- Genzyme Drug Discovery & Development
- PathoGenesis Corp.
- King Pharmaceuticals Inc.
- Jones Pharma Inc.
- Life Technologies Corp.
- Dexter Corp.
- Elan Corp. PLC
- Dura Pharmaceuticals Inc.
- Rita Medical Systems completes IPO
- Curon Medical nets $56mm in IPO
- Siemens buys Acuson for $700mm in cash
- Variagenics nets $65mm in 5mm share IPO
- Third Wave raises $48mm through private placement
- Ingenium Pharmaceuticals raises $43.36mm in private financing
- bioMerieux, Pierre Fabre merge; then part ways
- Sigma Diagnostics buys coag. instrument company Amelung
- Sigma Diagnostics buys POC Dx company First Medical
- Serono raises $967mm in global offering
- Genzyme to buy GelTex in $1bn cash/stock deal
- Chiron acquires PathoGenesis for $729mm
- King buys Jones in $3.2bn stock transaction
- Invitrogen acquires Dexter and Life Technologies
- Elan acquires Dura Pharmaceuticals for $1.69bn
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.